Skip to main content

Joe Mangano's Credibility Takes Another Body Blow

By Eric McErlain
This time, the sledgehammer is delivered courtesy of Barbara Feder Ostrov's Health Journalism Blog. Like plenty of other folks, she was shocked at Joe Mangano's claims -- ones that he backed off from when under questioning from MedPage Today -- so she talked to some long-time medical journalists.

Here's what Ivan Oransky of Reuters Health had to say about Mangano's research:
I do use impact factor to judge journals, while accepting that it's an imperfect measure that is used in all sorts of inappropriate ways (and, for the sake of full disclosure, is a Thomson Scientific product, as in Thomson Reuters). I find it helpful to rank journals within a particular specialty.

[...]

I looked up the journal in question, and it's actually ranked 45th out of 58 in the Health Policy and Services category (in the social sciences rankings) and 59th out of 72 in the Health Care Sciences & Services category (in the science rankings).
Here's Gary Schwitzer of Health News Review:
Journalists who live on a steady diet of journal articles almost by definition promote a rose-colored view of progress in research if they don't grasp and convey the publication bias in many journals for positive findings. Negative or null findings may not be viewed as sexy enough. Or they may be squelched prior to submission. While perhaps not a factor in this one case, it nonetheless drives home the point to journalists about the need to critically evaluate studies.
I'm afraid I have more bad news for Mangano. Who's going to tell Christie Brinkley?

Labels

Labels:

Comments

Brian Mays said…
Int J Health Serv is a rather obscure journal, which has been used by Mangano, Sherman, and some of Mangano's old colleagues (e.g., Sternglass and Gould) for a couple of decades or so to publish dubious papers such as this.

It looks like Mangano has a sympathetic editor, who is willing to set up his papers for softball reviews (so-called "Pal Review," rather than rigorous peer review) and who is willing to publish just about anything that Mangano gives him.
December 21, 2011 at 6:46 PM
Robert said…
Joe Mangano - Doesn't his wife Joy Mangano sell miracle mops on QVC?
December 22, 2011 at 4:52 AM
Post a Comment

Popular posts from this blog

Wednesday Update

By
From NEI’s Japan micro-site: NRC, Industry Concur on Many Post-Fukushima Actions Industry/Regulatory/Political Issues • There is a “great deal of alignment” between the U.S. Nuclear Regulatory Commission and the industry on initial steps to take at America’s nuclear energy facilities in response to the nuclear accident in Japan, Charles Pardee, the chief operating officer of Exelon Generation Co., said at an agency briefing today. The briefing gave stakeholders an opportunity to discuss staff recommendations for near-term actions the agency may take at U.S. facilities. PowerPoint slides from the meeting are on the NRC website. • The International Atomic Energy Agency board has approved a plan that calls for inspectors to evaluate reactor safety at nuclear energy facilities every three years. Governments may opt out of having their country’s facilities inspected. Also approved were plans to maintain a rapid response team of experts ready to assist facility operators recoverin...
Post a Comment
Read more

Fluor Invests in NuScale

By
You know, it’s kind of sad that no one is willing to invest in nuclear energy anymore. Wait, what? NuScale Power celebrated the news of its company-saving $30 million investment from Fluor Corp. Thursday morning with a press conference in Washington, D.C. Fluor is a design, engineering and construction company involved with some 20 plants in the 70s and 80s, but it has not held interest in a nuclear energy company until now. Fluor, which has deep roots in the nuclear industry, is betting big on small-scale nuclear energy with its NuScale investment. "It's become a serious contender in the last decade or so," John Hopkins, [Fluor’s group president in charge of new ventures], said. And that brings us to NuScale, which had run into some dark days – maybe not as dark as, say, Solyndra, but dire enough : Earlier this year, the Securities Exchange Commission filed an action against NuScale's lead investor, The Michael Kenwood Group. The firm "misap...
1 comment
Read more

Nuclear Utility Moves Up in Credit Ratings, Bank is "Comfortable with Nuclear Strategy"

By
Some positive signs that nuclear utilities can continue to receive positive ratings even while they finance new nuclear plants for the first time in decades: Wells Fargo upgrades SCANA to Outperform from Market Perform Wells analyst says, "YTD, SCG shares have underperformed the Regulated Electrics (total return +2% vs. +9%). Shares trade at 11.3X our 10E EPS, a modest discount to the peer group median of 11.8X. We view the valuation as attractive given a comparatively constructive regulatory environment and potential for above-average long-term EPS growth prospects ... Comfortable with Nuclear Strategy. SCG plans to participate in the development of two regulated nuclear units at a cost of $6.3B, raising legitimate concerns regarding financing and construction. We have carefully considered the risks and are comfortable with SCG’s strategy based on a highly constructive political & regulatory environment, manageable financing needs stretched out over 10 years, strong partners...
Post a Comment
Read more